Yunfeng Zhou Selected Research

Telomere-Binding Proteins

3/2014	Suppression of telomere-binding protein TPP1 resulted in telomere dysfunction and enhanced radiation sensitivity in telomerase-negative osteosarcoma cell line.
1/2014	PTOP and TRF1 help enhance the radio resistance in breast cancer cell.
1/2013	Telomere-binding protein TPP1 modulates telomere homeostasis and confers radioresistance to human colorectal cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yunfeng Zhou Research Topics

Disease

49	Neoplasms (Cancer) 05/2022 - 11/2006
9	Breast Neoplasms (Breast Cancer) 02/2020 - 03/2009
7	Carcinogenesis 01/2021 - 01/2016
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2017
6	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 01/2013
6	Fibrosis (Cirrhosis) 11/2021 - 03/2012
6	Carcinoma (Carcinomatosis) 01/2021 - 02/2015
6	Inflammation (Inflammations) 02/2020 - 01/2008
5	Triple Negative Breast Neoplasms 01/2021 - 05/2015
5	Stomach Neoplasms (Stomach Cancer) 04/2019 - 01/2015
5	Prostatic Neoplasms (Prostate Cancer) 03/2019 - 08/2013
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 12/2011
4	Infections 07/2021 - 01/2015
4	Urinary Bladder Neoplasms (Bladder Cancer) 03/2021 - 10/2013
4	Neoplasm Metastasis (Metastasis) 10/2020 - 12/2010
4	Renal Cell Carcinoma (Grawitz Tumor) 10/2018 - 11/2015
3	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 05/2020
3	Hypoxia (Hypoxemia) 10/2020 - 01/2019
3	Nasopharyngeal Carcinoma 01/2020 - 10/2016
3	Proteinuria 03/2018 - 06/2011
2	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2013
2	Melanoma (Melanoma, Malignant) 10/2021 - 05/2017
2	Hypertension (High Blood Pressure) 01/2021 - 03/2018
2	Osteosarcoma (Osteogenic Sarcoma) 12/2019 - 03/2014
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 06/2019 - 01/2018
2	Wounds and Injuries (Trauma) 03/2018 - 06/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 01/2017
2	Hyperglycemia 02/2017 - 05/2014
2	Non-alcoholic Fatty Liver Disease 01/2017 - 08/2013
2	Fatty Liver 01/2017 - 08/2013
2	Glioma (Gliomas) 11/2016 - 12/2012
2	Diabetic Nephropathies (Diabetic Nephropathy) 07/2015 - 01/2012
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2015 - 09/2009
2	Kidney Diseases (Kidney Disease) 01/2013 - 01/2012
2	Lewis Lung Carcinoma 09/2011 - 04/2011
1	Metabolic Bone Diseases (Osteopenia) 11/2022
1	Chemical and Drug Induced Liver Injury 12/2021
1	Chronic Renal Insufficiency 11/2021
1	Adenoid Cystic Carcinoma (Cylindroma) 07/2021
1	Neuroinflammatory Diseases 01/2021

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2011
12	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2020 - 09/2009
8	LuciferasesIBA 05/2016 - 07/2013
6	MicroRNAs (MicroRNA)IBA 10/2020 - 06/2014
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2017
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2008
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2013
4	EnzymesIBA 01/2020 - 09/2009
3	apatinibIBA 07/2021 - 01/2021
3	Cyclin D1IBA 01/2021 - 01/2013
3	ZincIBA 01/2020 - 01/2009
3	Clioquinol (Vioform)FDA Link 01/2020 - 01/2009
3	Pharmaceutical PreparationsIBA 03/2019 - 06/2011
3	Messenger RNA (mRNA)IBA 10/2018 - 01/2015
3	Telomere-Binding ProteinsIBA 03/2014 - 01/2013
3	LigandsIBA 01/2012 - 01/2008
3	Horseradish PeroxidaseIBA 09/2011 - 09/2009
2	Biological ProductsIBA 05/2022 - 01/2019
2	Glucose OxidaseIBA 01/2022 - 01/2020
2	CytokinesIBA 11/2021 - 12/2017
2	Long Noncoding RNAIBA 01/2021 - 10/2018
2	CyclinsIBA 01/2021 - 12/2019
2	Angiogenesis InhibitorsIBA 01/2021 - 01/2021
2	ribociclibIBA 12/2019 - 04/2019
2	Therapeutic UsesIBA 05/2019 - 12/2007
2	AntigensIBA 03/2019 - 07/2015
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 03/2018 - 01/2017
2	Mitochondrial DNA (mtDNA)IBA 01/2018 - 01/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2017 - 09/2008
2	Ubiquitin-Conjugating EnzymesIBA 05/2016 - 01/2016
2	Dual OxidasesIBA 01/2016 - 01/2016
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 02/2015 - 04/2014
2	Small Interfering RNA (siRNA)IBA 05/2014 - 11/2006
2	ErbB Receptors (EGF Receptor)IBA 10/2013 - 03/2012
2	Triglycerides (Triacylglycerol)IBA 08/2013 - 09/2008
2	Transcription Factors (Transcription Factor)IBA 01/2012 - 09/2008
2	indoleIBA 09/2011 - 04/2011
2	Interleukin-12 (IL 12)IBA 09/2011 - 04/2011
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2011 - 01/2008
1	AlbuminsIBA 11/2022
1	PhosphoglucomutaseIBA 05/2022
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2022
1	Hemin (Panhematin)FDA Link 01/2022
1	Drug CarriersIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 12/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2021
1	Pepsinogen CIBA 07/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2021
1	yuan zhiIBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021

Therapy/Procedure

18	Radiotherapy 01/2022 - 09/2009
15	Therapeutics 01/2022 - 11/2006
4	Chemoradiotherapy 06/2022 - 01/2019
4	Drug Therapy (Chemotherapy) 10/2020 - 01/2012
3	Immunotherapy 01/2022 - 01/2021
2	Adjuvant Radiotherapy 02/2020 - 04/2019
2	Arthroscopes 07/2019 - 07/2019
2	Anterior Cruciate Ligament Reconstruction 12/2017 - 12/2017
1	Immunomodulation 11/2021